TriSalus Life Sciences is proud to announce our participation in the SIO 2026 Annual Scientific Meeting, held from February 4-8, 2026, in Savannah, Georgia.
Come meet with our team to learn more about The TriNav® Infusion System with SmartValve® technology, and how Pressure-Enabled Drug Delivery™ (PEDD) is revolutionizing precision embolization of solid tumors.
Visit Us at Booth #303
February 4-8, 2026
Savannah Convention Center, Exhibit Hall
Attend Our Lunch Symposium
Why Pressure Matters: Optimizing Embolic Delivery using TriNav
How Pressure-Enabled Drug Delivery Works and What Real Cases Reveal
Join us for an in-depth exploration of how PEDD may help overcome barriers to improve therapeutic distribution and clinical outcomes.
Thursday, February 5, 2026
12:45 PM – 1:45 PM
Chatham Ballroom B
Featured Speakers
Zachary Berman, MD
Associate Clinical Professor of Radiology
University of California, San Diego
Zachary T. Berman, MD is an interventional radiologist who performs minimally invasive image guided procedures. He specializes in liver directed therapies for hepatocellular carcinoma and metastatic liver disease such as transarterial radioembolization (TARE/SIRT), transarterial chemoembolization (TACE), and percutaneous ablation (microwave, radiofrequency and cryoablation).
As an assistant professor at UC San Diego School of Medicine, he instructs medical students, residents, and fellows in the Department of Radiology. Dr. Berman is energized by the ability to conduct cutting edge research to expand and improve the delivery of minimally invasive procedures. He is actively engaged in clinical trials directed toward primary and metastatic liver disease treatments, specifically the improved use of Yttrium-90 Radioembolization.
Dr. Berman is a member of the Society of Interventional Radiology, the Society of Interventional Oncology and the Radiologic Society of North America.
Venkatesh (Kavi) Krishnasamy, MD
Director of Interventional Oncology and Interventional Research
University of Alabama Birmingham
Venkatesh (Kavi) Krishnasamy, MD is the Director of Interventional Oncology and Interventional Research at the University of Alabama Birmingham. His clinical focus is primarily the full gamut of Interventional Oncology and MSK/pain interventions. In particular, he specializes in complex percutaneous ablation and transarterial therapies with adjunctive techniques.
Dr. Krishnasamy’s academic interests include device/software development, translational research, and multidisciplinary oncology trials. He additionally focuses on therapeutic guideline and algorithm development.
Plan Your Visit
To learn more about SIO 2026 or to register for the event, please visit the official conference website. We look forward to seeing you in Savannah and working to improve clinical outcomes together.
